Gene · 51564
Papers2,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy. | Mol Med Rep | 2024 | 39329199 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases. | J Enzyme Inhib Med Chem | 2024 | 39316378 | PubTator, text mining | PubMed |
| Melatonin Attenuates Diabetic Retinopathy by Regulating EndMT of Retinal Vascular Endothelial Cells via Inhibiting the HDAC7/FOXO1/ZEB1 Axis. | J Pineal Res | 2024 | 39300782 | PubTator, text mining | PubMed |
| HDAC7 is a potential therapeutic target in acute erythroid leukemia. | Leukemia | 2024 | 39277669 | PubTator, text mining | PubMed |
| Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis. | Front Genet | 2024 | 39238786 | PubTator, text mining | PubMed |
| The role of ubiquitin-conjugating enzyme in the process of spermatogenesis. | Reprod Biol Endocrinol | 2024 | 39198846 | PubTator, text mining | PubMed |
| Mechanism and application of feedback loops formed by mechanotransduction and histone modifications. | Genes Dis | 2024 | 39071110 | PubTator, text mining | PubMed |
| The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors. | Int J Mol Sci | 2024 | 39063083 | PubTator, text mining | PubMed |
| Differential Gene Expression Involved in Bone Turnover of Mice Expressing Constitutively Active TGFβ Receptor Type I. | Int J Mol Sci | 2024 | 38892016 | PubTator, text mining | PubMed |
| Unveiling blood pressure-associated genes in aortic cells through integrative analysis of GWAS and RNA modification-associated variants. | Chronic Dis Transl Med | 2024 | 38872756 | PubTator, text mining | PubMed |
| Tweety homolog 3 promotes colorectal cancer progression through mutual regulation of histone deacetylase 7. | MedComm (2020) | 2024 | 38827027 | PubTator, text mining | PubMed |
| Stimuli-responsive microcarriers and their application in tissue repair: A review of magnetic and electroactive microcarrier. | Bioact Mater | 2024 | 38808158 | PubTator, text mining | PubMed |
| Stem-Cell-Driven Chondrogenesis: Perspectives on Amnion-Derived Cells. | Cells | 2024 | 38727280 | PubTator, text mining | PubMed |
| Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities. | Daru | 2024 | 38683491 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviate Brain Damage Following Subarachnoid Hemorrhage via the Interaction of miR-140-5p and HDAC7. | Mol Neurobiol | 2024 | 38592585 | PubTator, text mining | PubMed |
| Protein crotonylation: Basic research and clinical diseases. | Biochem Biophys Rep | 2024 | 38586826 | PubTator, text mining | PubMed |
| Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA. | J Mol Biol | 2024 | 38492719 | PubTator, text mining | PubMed |
| HDAC7: a promising target in cancer. | Front Oncol | 2024 | 38487728 | PubTator, text mining | PubMed |
| Epigenetic Switches in Retinal Homeostasis and Target for Drug Development. | Int J Mol Sci | 2024 | 38474086 | PubTator, text mining | PubMed |
| "DompeKeys": a set of novel substructure-based descriptors for efficient chemical space mapping, development and structural interpretation of machine learning models, and indexing of large databases. | J Cheminform | 2024 | 38395961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51564/papers?page=5